Shelter Pharma secures ₹50,347 order from Verka Dairy for vet supplements

1 min read     Updated on 24 Jul 2026, 11:45 AM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Shelter Pharma Ltd announced a ₹50,347.50 order from Verka Dairy Ludhiana for veterinary feed supplements. The domestic deal, disclosed under SEBI LODR regulations, includes supplies of DIA-VET BLOUS and UTRON. Management views this as a positive indicator for future revenue growth and client confidence.

powered bylight_fuzz_icon
46419340

*this image is generated using AI for illustrative purposes only.

Shelter Pharma has secured a purchase order from Verka Dairy Ludhiana for the supply of veterinary feed supplements, marking a new business acquisition in the domestic market. The order, valued at ₹50,347.50, was received in the normal course of business on July 24, 2026. This engagement with Verka Dairies, the flagship brand of MILKFED Punjab, underscores growing demand for specialized veterinary inputs among major dairy cooperatives in North India.

The transaction is classified as a domestic order and does not involve any related party transactions or interests from the promoter group. Shelter Pharma’s Board highlighted that the award reflects the client's confidence in the company's ability to deliver quality solutions efficiently. The order is expected to contribute positively to the company's future revenues and overall business growth.

Order Details

The purchase order covers two specific veterinary feed supplement products. The financial breakdown and product specifications are detailed below:

Product Name Unit Quantity Unit Price (₹) Total Value (₹)
DIA-VET BLOUS NOS 1000x17.20 17200.00
UTRON (For retention of Placenta/Ecbloic) Each 600x51.25 30750.00
Total 50347.50

The company must execute the order within mutually agreed timelines as per the purchase order schedule. The products are intended for veterinary use within the dairy operations, specifically targeting animal health and productivity.

Regulatory Compliance

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation was submitted to BSE Limited by Mustaqim Nisar Ahmed Sabugar, Managing Director of Shelter Pharma Limited. The filing confirms that the transaction is conducted at arm's length and falls outside the scope of related party transactions.

What the Numbers Show

While the absolute value of ₹50,347.50 is modest in the context of large-cap pharmaceutical contracts, the strategic significance lies in the client profile. Securing a contract with Verka Dairies, a major entity under MILKFED Punjab, validates Shelter Pharma’s product efficacy in a highly competitive regional market. For specialty chemical and veterinary input manufacturers, entry into the supply chain of large dairy cooperatives often serves as a gateway to recurring revenue streams, given the continuous need for animal health supplements. The absence of promoter interest ensures the transaction is purely commercial, reflecting organic demand rather than internal channeling.

Historical Stock Returns for Shelter Pharma

1 Day5 Days1 Month6 Months1 Year5 Years
-1.85%+1.92%-9.40%-30.26%-41.02%-36.84%

Will Shelter Pharma pursue similar contracts with other major dairy cooperatives across India to scale this new revenue stream?

How significant is the veterinary feed supplement segment expected to be in Shelter Pharma's overall revenue mix over the next fiscal year?

Does this order indicate a broader strategic shift for Shelter Pharma towards domestic agricultural and veterinary markets rather than just pharmaceuticals?

Shelter Pharma wins USD 27,664 international order

1 min read     Updated on 10 Jul 2026, 01:22 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Shelter Pharma secured a USD 27,664 international order from Al-Saqr Agro for veterinary feed supplements. The order includes Multina Liquid and Super Vitamas, with 100% advance payment and delivery within two months.

powered bylight_fuzz_icon
45215157

*this image is generated using AI for illustrative purposes only.

Shelter Pharma has secured a significant international purchase order worth USD 27,664 from Al-Saqr Agro for Agricultural and Veterinary Entries. The order involves the supply of veterinary feed supplements, specifically Multina Liquid and Super Vitamas, marking a milestone in the company's expansion into global markets. This development is expected to strengthen the company's international presence and contribute positively to its revenue growth.

The order was received in the normal course of business and includes specific product quantities and pricing. The company will supply Multina Liquid in 1L and 3L units, alongside Super Vitamas in 20kg units. The transaction is conducted at arm's length, with no interest held by the promoter, promoter group, or group companies in the buyer entity.

Payment terms require 100% advance at the time of the order, with prices based on Cost and Freight (CNF) terms. The delivery timeline is set for two months from the date of payment. The order execution will follow mutually agreed timelines as per the purchase order and shipment schedule.

Order Details

Particulars Details
Buyer Name Al-Saqr Agro for Agricultural and Veterinary Entries
Order Type International Entity
Order Value USD 27,664
Payment Terms 100% advance at the time of order
Delivery Time 2 Months from payment
Pricing Basis CNF

Product Breakdown

Product Unit Quantity Value (USD)
Multina Liquid 1L 1020 3,264
Multina Liquid 3L 1000 9,000
Super Vitamas 20kg 700 15,400

Historical Stock Returns for Shelter Pharma

1 Day5 Days1 Month6 Months1 Year5 Years
-1.85%+1.92%-9.40%-30.26%-41.02%-36.84%

Could this initial order from Al-Saqr Agro serve as a gateway for Shelter Pharma to establish a broader distribution network across Middle Eastern agricultural markets?

How might Shelter Pharma scale its manufacturing capacity to accommodate potentially larger repeat orders if this international partnership proves successful?

What regulatory approvals or certifications might Shelter Pharma need to pursue in order to expand its veterinary feed supplement exports to additional international markets beyond this transaction?

More News on Shelter Pharma

Must Read Next

Earnings

Apar Industries Reports Strong Q1 Performance: Revenue Surges to 65.9B Rupees, Net Profit Rises to 4.5B Rupees just now
no imag found

Corporate Actions

Ice Make Refrigeration Board Approves Share Subscription Deal with Galilei Holdings and Fresh Equity Issue for Non-Promoter Group just now
1 Year Returns:-41.02%